Project HERA 2

Project HERA 2

Project number: 101113387

Project name: Genomic surveillance of selected infectious diseases in the Czech Republic

Project acronym: HERA2CZ

Call: EU4H-2022-DGA-MS-IBA-1

The Name of the Call: Direct grants to Member States’ authorities: Enhancing whole genome sequencing (WGS) and/or reverse transcription polymerase chain reaction (RT-PCR) national infrastructures and capacities to respond to the COVID-19 pandemic and future health threats

Topic: EU4H-2022-DGA-MS-IBA-01-02

Topic Name: Consolidation of WGS and RT-PCR activities in countries that received support in 2021 aiming to ensure the sustainable use and integration of enhanced infrastructure into routine surveillance and outbreak investigation activities, in synergy with relevant on-going work at international level.

Type of action: EU4H-PJG

Project start: 1/10/2022

Project end: 30/6/2025

Project Duration: 33 months

Funding: The European Health and Digital Executive Agency (HADEA)

Grant: 1 393 630 EUR

Beneficiary: National Institute of Public Health

Partners/Affiliated Entities: none

 

Project Goals:

The project aims to improve the capacity of National Reference Laboratories (NRLs) in the National Institute of Public Health (NIPH) in Prague for genotypic characterization of a range of human pathogens (especially SARS-CoV-2 and other respiratory viruses, bacterial pathogens with cross-border threat potential, including antibiotic-resistant bacteria) with public health significance. The whole genome sequencing (WGS) is currently the state-of-the-art method for detailed characterization of microorganisms, as it provides a complete description of the genetic information of a given microorganism and its objective outputs allow immediate interlaboratory comparisons at the national and international levels.

The aim of the project is to improve the availability of genomic surveillance of communicable diseases in order to identify and characterize specific determinants for the description and identification of clonal lineages with significant potential for their spread. The project responds to the need to ensure genomic surveillance within European structures (specifically the ECDC). Without the implementation of routine genomic surveillance, monitoring and addressing national and cross-border threats of infectious diseases and antibiotic resistance is not possible.

Final Conference of the HERA2CZ Project
The Centre for Epidemiology and Microbiology (CEM) of the National Institute of Public Health in Prague, in cooperation with the implementation team of the HERA2CZ project (Genomic Surveillance of Selected Infectious Diseases in the Czech Republic), organized a one-day conference titled Results of the HERA2CZ Project and Consultation Day of the Centre for Epidemiology and Microbiology (CEM) on March 5, 2025, at the premises of the National Institute of Public Health.

The event attracted Czech and Slovak experts in epidemiology, microbiology, and Public health, who were introduced to the latest findings and outputs of the project focused on implementing genomic surveillance of selected infectious diseases in the Czech Republic.

Program (CZ) – Results of the HERA2CZ Project (Project on Genomic Surveillance of Selected Infectious Diseases in the Czech Republic) and Consultation Day of the Centre for Epidemiology and Microbiology (CEM)

This project directly builds on the previous project granted under ECDC procedure ECDC/HERA/2021/004.ECD.12218. More information about the HERA project.

Project Press Release

 

The project consists of 5 work packages (WP):

  • Leader: Jana Kozáková
  • Project management, evaluation, communication and sustainability –MNGECS. WP’s objective focuses on the effective management, coordination, communication, evaluation, and sustainability of the project. Management efforts prioritize achieving overall project objectives within the budget and timeline, emphasizing coordination of work plans and progress among Work Package leaders and ensuring accurate reporting. Communication strategies include developing a Communication strategy to reach target audiences and raise awareness of key project outcomes. Evaluation processes involve assessing specific project objectives and maintaining high-quality standards for produced data. WP1 also focuses on the sustainability of project results by elaborating on a plan for exploiting enhanced knowledge and infrastructure for improved cooperation in pathogen surveillance.
  • Leader: Jana Kozáková
  • Vaccine Preventable Diseases (invasive meningococcal disease, invasive pneumococcal disease, invasive disease caused by Haemophilus, invasive disease caused by B. pertussis) – VACPREV. WP4’s objective is the implementation of whole genome sequencing (WGS) as a routine practice in National Reference Laboratories (NRLs) responsible for national disease surveillance caused by meningococci, pneumococci, haemophilus, and B. pertussis. The WGS data generated within the project will be reported to the international databases for outbreak investigations, control-oriented surveillance, and strategy-oriented surveillance of invasive diseases caused by the pathogens mentioned. The implementation involves establishing WGS protocols, which include DNA extraction, quality control, sequencing library preparation, and data analysis. The purchase of WGS sequencing equipment within the project will enhance the ability to perform WGS for agents mentioned contributing to improved disease surveillance and control.
  • Publications related to WP4
  • Other sources:
  • Leader: Helena Žemličková
  • Antimicrobial resistance genes surveillance – ATBRES. WP’s objective focuses on implementing whole genome sequencing (WGS) into European surveillance and national/international outbreak investigations, and enhancing diagnostic capabilities to detect carbapenem-resistant and/or colistin-resistant Enterobacterales (CRE/CCRE). The primary objectives include implementing standardized WGS-based genome analysis methods, performing quality control on WGS, identifying genetic determinants associated with antibiotic resistance, and confirming and identifying outbreaks of priority pathogens linked to antimicrobial resistance (AMR). The ultimate goal is to establish a robust methodology for WGS and effective tools for enhanced surveillance of bacteria contributing to the spread of antibiotic resistance.
  • Publications related to WP5
  • Other sources:

Press releases, leaflets, links

Project’s Coordinator: 

Jana Kozáková, MD

00420 267 082 101
jana.kozakova@szu.gov.cz

 

Acknowledgement of funding:


Project „Genomic surveillance of selected infectious diseases in the Czech Republic“ (HERA2CZ) was funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the European Health and Digital Executive Agency (HADEA) can be held responsible for them.